Drupal.behaviors.print = function(context) {window.print();window.close();}>
Qiagen Gains Approval in Japan for EGFR Companion Dx, Acquires Rights to New Markers
January 10, 2012
Qiagen Gains Approval in Japan for EGFR Companion Dx, Acquires Rights to New Markers
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
NCI Awards Contracts to Insight Genetics to Develop NSCLC CDx
November 12, 2012 / GenomeWeb Daily News
Insight Genetics Wins $1.5M Grant to Begin Clinical Testing for ALK Mutation CDx on Qiagen Platform
October 11, 2012 / PCR Insider
Insight Genetics Snags $193K NCI SBIR Grant to Develop CDx for ALK Resistance
October 5, 2011 / GenomeWeb Daily News
Roche Receives FDA Nod for New PGx Indication for Tarceva in Metastatic NSCLC with Companion Dx
May 15, 2013 / Pharmacogenomics Reporter
Qiagen, Eli Lilly Enter CDx Deal
February 14, 2013 / GenomeWeb Daily News